Takeda Pharmaceutical Company Limited
PROPHYLACTIC OR THERAPEUTIC AGENT FOR AUTISM SPECTRUM DISORDER
Last updated:
Abstract:
The present invention provides a prophylactic or therapeutic agent for an autism spectrum disorder containing compound (I) having melatonin receptor affinity. A compound represented by the formula: ##STR00001## wherein each symbol is as described in the specification, or a salt thereof.
Status:
Application
Type:
Utility
Filling date:
22 Jul 2020
Issue date:
6 May 2021